| 51 |
29434452 | PIK3CA and TP53 mutations predict overall survival of stage II/III colorectal cancer patients. | 2018 Feb 7 |
2 |
| 52 |
29436749 | HOXA13 contributes to gastric carcinogenesis through DHRS2 interacting with MDM2 and confers 5-FU resistance by a p53-dependent pathway. | 2018 Jun |
2 |
| 53 |
29702091 | Inhibition of MALAT1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKKα/NF-κB pathway. | 2018 Jun 18 |
1 |
| 54 |
29738772 | Dihydroartemisinin potentiates antitumor activity of 5-fluorouracil against a resistant colorectal cancer cell line. | 2018 Jun 27 |
1 |
| 55 |
29772519 | p53 and P-glycoprotein influence chemoresistance in hepatocellular carcinoma. | 2018 Jun 1 |
1 |
| 56 |
29795190 | Renal inhibition of miR-181a ameliorates 5-fluorouracil-induced mesangial cell apoptosis and nephrotoxicity. | 2018 May 23 |
3 |
| 57 |
29980405 | Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals. | 2018 Aug |
2 |
| 58 |
30056083 | Manuka honey synergistically enhances the chemopreventive effect of 5-fluorouracil on human colon cancer cells by inducing oxidative stress and apoptosis, altering metabolic phenotypes and suppressing metastasis ability. | 2018 Oct |
1 |
| 59 |
30059758 | Chemosensitivity of human colon cancer cells is influenced by a p53-dependent enhancement of ceramide synthase 5 and induction of autophagy. | 2018 Oct |
7 |
| 60 |
30111797 | Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells. | 2018 Aug 14 |
1 |
| 61 |
30374014 | Expression of Micro-RNA-492 (MiR-492) in Human Cervical Cancer Cell Lines is Upregulated by Transfection with Wild-Type P53, Irradiation, and 5-Fluorouracil Treatment In Vitro. | 2018 Oct 30 |
1 |
| 62 |
30539860 | Autophagy facilitates anticancer effect of 5-fluorouracil in HCT-116 cells. | 2018 Dec |
2 |
| 63 |
30613833 | Improved potency of F10 relative to 5-fluorouracil in colorectal cancer cells with p53 mutations. | 2018 |
3 |
| 64 |
27637603 | The Presence of Serum p53 Antibody Predicts the Pathological Tumor Response to Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and Fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma. | 2017 Feb |
1 |
| 65 |
28000054 | 5-Flurouracil disrupts nuclear export and nuclear pore permeability in a calcium dependent manner. | 2017 Mar |
1 |
| 66 |
28028695 | 5-Fluorouracil inhibits cell migration by induction of Sestrin2 in colon cancer cells. | 2017 Feb |
4 |
| 67 |
28178647 | Enhancement of TRAIL-induced apoptosis by 5-fluorouracil requires activating Bax and p53 pathways in TRAIL-resistant lung cancers. | 2017 Mar 14 |
3 |
| 68 |
28284059 | Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin. | 2017 Apr |
1 |
| 69 |
28296564 | AZD1775 induces toxicity through double-stranded DNA breaks independently of chemotherapeutic agents in p53-mutated colorectal cancer cells. | 2017 |
1 |
| 70 |
28352348 | Gambogic acid potentiates the chemosensitivity of colorectal cancer cells to 5-fluorouracil by inhibiting proliferation and inducing apoptosis. | 2017 Feb |
2 |
| 71 |
28416637 | A Kinase-Independent Role for Cyclin-Dependent Kinase 19 in p53 Response. | 2017 Jul 1 |
2 |
| 72 |
28529594 | An active molecule from Pulsatilla chinensis, Pulsatilla saponin A, induces apoptosis and inhibits tumor growth of human colon cancer cells without or with 5-FU. | 2017 May |
1 |
| 73 |
28656647 | Epigenetic silencing of ASPP1 confers 5-FU resistance in clear cell renal cell carcinoma by preventing p53 activation. | 2017 Oct 1 |
1 |
| 74 |
28816773 | Synergistic antitumor effect of 3-bromopyruvate and 5-fluorouracil against human colorectal cancer through cell cycle arrest and induction of apoptosis. | 2017 Sep |
1 |
| 75 |
28851987 | P53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase (DPYD) expression in response to thymidylate synthase (TS) targeting. | 2017 Aug 29 |
6 |
| 76 |
28928082 | miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin. | 2017 Nov 15 |
5 |
| 77 |
29020632 | Activation of the p53 Transcriptional Program Sensitizes Cancer Cells to Cdk7 Inhibitors. | 2017 Oct 10 |
1 |
| 78 |
29061672 | miR-6883 Family miRNAs Target CDK4/6 to Induce G1 Phase Cell-Cycle Arrest in Colon Cancer Cells. | 2017 Dec 15 |
1 |
| 79 |
25961931 | Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate. | 2016 Feb 25 |
1 |
| 80 |
26691280 | Apoptotic activity of 5-fluorouracil in breast cancer cells transformed by low doses of ionizing α-particle radiation. | 2016 Feb |
1 |
| 81 |
26774139 | Chidamide and 5-flurouracil show a synergistic antitumor effect on human colon cancer xenografts in nude mice. | 2016 |
3 |
| 82 |
26840457 | Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein. | 2016 Feb 23 |
2 |
| 83 |
26892272 | Lupeol enhances inhibitory effect of 5-fluorouracil on human gastric carcinoma cells. | 2016 May |
1 |
| 84 |
27009858 | Activation of anaphase-promoting complex by p53 induces a state of dormancy in cancer cells against chemotherapeutic stress. | 2016 May 3 |
1 |
| 85 |
27044842 | The novel anthraquinone derivative IMP1338 induces death of human cancer cells by p53-independent S and G2/M cell cycle arrest. | 2016 Apr |
2 |
| 86 |
27129209 | E2 Ubiquitin-conjugating Enzyme, UBE2C Gene, Is Reciprocally Regulated by Wild-type and Gain-of-Function Mutant p53. | 2016 Jul 1 |
1 |
| 87 |
27144434 | MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism. | 2016 Jun 7 |
1 |
| 88 |
27527606 | Highly activated p53 contributes to selectively increased apoptosis of latently HIV-1 infected cells upon treatment of anticancer drugs. | 2016 Aug 16 |
6 |
| 89 |
27534737 | Correction: 5-Fluorouracil-induced RNA stress engages a TRAIL-DISC-dependent apoptosis axis facilitated by p53. | 2016 May 10 |
1 |
| 90 |
27591972 | Role of 3' repressor sequences of p53 in anti-cancer drug sensitivity of human lung tumor cells. | 2016 Dec 15 |
2 |
| 91 |
27621580 | Synergistic anticancer effect of exogenous wild-type p53 gene combined with 5-FU in human colon cancer resistant to 5-FU in vivo. | 2016 Aug 28 |
19 |
| 92 |
27777774 | 5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers. | 2016 |
2 |
| 93 |
27835895 | Enhancement of 5-FU sensitivity by the proapoptotic rpL3 gene in p53 null colon cancer cells through combined polymer nanoparticles. | 2016 Nov 29 |
1 |
| 94 |
27924828 | rpL3 promotes the apoptosis of p53 mutated lung cancer cells by down-regulating CBS and NFκB upon 5-FU treatment. | 2016 Dec 7 |
2 |
| 95 |
28053293 | Correction: 5-Fluorouracil-induced RNA stress engages a TRAIL-DISC-dependent apoptosis axis facilitated by p53. | 2016 Nov 1 |
1 |
| 96 |
28105142 | Antitumor effects of recombinant human adenovirus-p53 against human cutaneous squamous cell carcinoma in mice. | 2016 Dec |
1 |
| 97 |
25310623 | 5‑FU resistance abrogates the amplified cytotoxic effects induced by inhibiting checkpoint kinase 1 in p53‑mutated colon cancer cells. | 2015 Jan |
3 |
| 98 |
25348361 | DNA-PKcs deficiency sensitizes the human hepatoma HepG2 cells to cisplatin and 5-fluorouracil through suppression of the PI3K/Akt/NF-κB pathway. | 2015 Jan |
1 |
| 99 |
25502560 | Indirect modulation of sensitivity to 5-fluorouracil by microRNA-96 in human colorectal cancer cells. | 2015 Feb |
1 |
| 100 |
25616665 | MicroRNA-520g confers drug resistance by regulating p21 expression in colorectal cancer. | 2015 Mar 6 |
1 |